COSMO Pharmaceuticals SA (0RGI) — Cash Flow Quality Index
COSMO Pharmaceuticals SA (0RGI) has a Cash Flow Quality Index of 0.82x as of December 2024. Operating cash flow of £63.23 Million is below net income of £77.38 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore COSMO Pharmaceuticals SA (0RGI) total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
COSMO Pharmaceuticals SA Cash Flow Quality Index (2005–2024)
Historical Cash Flow Quality Index for COSMO Pharmaceuticals SA across 16 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 0RGI tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for COSMO Pharmaceuticals SA (2005–2024)
Year-by-year earnings quality comparison for COSMO Pharmaceuticals SA. For live market cap and the full company financial profile, see COSMO Pharmaceuticals SA stock valuation.
| Year | Quality Index | Operating CF (GBP) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.06x | £162.41 Million | £153.37 Million | ▼ -92.9% |
| 2023 | 14.82x | £22.71 Million | £1.53 Million | ▲ +668.4% |
| 2022 | 1.93x | £32.89 Million | £17.05 Million | ▲ +267.1% |
| 2021 | 0.53x | £12.61 Million | £24.00 Million | ▼ -45.3% |
| 2016 | 0.96x | £26.41 Million | £27.49 Million | ▲ +722.8% |
| 2015 | -0.15x | £-39.23 Million | £254.29 Million | ▼ -125.3% |
| 2014 | 0.61x | £66.45 Million | £108.85 Million | ▲ +439.3% |
| 2013 | 0.11x | £8.11 Million | £71.67 Million | ▼ -86.8% |
| 2012 | 0.86x | £23.00 Million | £26.89 Million | ▼ -31.1% |
| 2011 | 1.24x | £11.29 Million | £9.09 Million | ▼ -28.9% |
| 2010 | 1.75x | £7.79 Million | £4.46 Million | ▲ +139.5% |
| 2009 | 0.73x | £3.88 Million | £5.32 Million | ▲ +154.8% |
| 2008 | -1.33x | £-12.52 Million | £9.40 Million | ▲ +93.9% |
| 2007 | -21.73x | £-2.52 Million | £116.00K | ▼ -387.1% |
| 2006 | 7.57x | £6.08 Million | £803.00K | ▲ +483.7% |
| 2005 | 1.30x | £1.70 Million | £1.31 Million | — |